PharmaShots | Incisive News in 3 Shots

Subscribe Now

rights

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

December 3, 2020

Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

October 5, 2020

Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M

May 13, 2020

Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia's Apealea

Elevar Therapeutics Acquires Worldwide Development and Commercialization Rights for Oasmia's Apealea

March 25, 2020

Collegium to Acquire US Rights of Assertio's Nucynta Franchise for $375M

Collegium to Acquire US Rights of Assertio's Nucynta Franchise for $375M

February 7, 2020

AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

December 20, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us